0.042
Precedente Chiudi:
$0.041
Aprire:
$0.0405
Volume 24 ore:
4.31M
Relative Volume:
0.13
Capitalizzazione di mercato:
$1.38M
Reddito:
$4.02M
Utile/perdita netta:
$-4.73M
Rapporto P/E:
-0.00998
EPS:
-4.21
Flusso di cassa netto:
$-5.85M
1 W Prestazione:
-8.70%
1M Prestazione:
-42.47%
6M Prestazione:
-89.94%
1 anno Prestazione:
-93.73%
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Nome
Petros Pharmaceuticals Inc
Settore
Telefono
973-242-0005
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Confronta PTPI con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PTPI
Petros Pharmaceuticals Inc
|
0.042 | 1.38M | 4.02M | -4.73M | -5.85M | -4.21 |
![]()
ZTS
Zoetis Inc
|
146.85 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
HLN
Haleon Plc Adr
|
10.19 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.93 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.31 | 15.25B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
284.25 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Petros Pharmaceuticals Inc Borsa (PTPI) Ultime notizie
Petros Pharmaceuticals stock hits 52-week low at $0.04 By Investing.com - Investing.com South Africa
Ratio Analysis: Unpacking Petros Pharmaceuticals Inc (PTPI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Petros Pharmaceuticals stock hits 52-week low at $0.04 - Investing.com
Petros Pharmaceuticals faces delisting, stockholders approve equity changes - Investing.com Australia
Petros Pharmaceuticals faces delisting, stockholders approve equity changes By Investing.com - Investing.com Canada
Petros Pharmaceuticals Approves Key Amendments to Incorporation - TipRanks
Petros Pharmaceuticals appoints new auditor for 2025 By Investing.com - Investing.com South Africa
Petros Pharmaceuticals appoints new auditor for 2025 - Investing.com
PTPI stock plunges to 52-week low of $0.05 amid market challenges By Investing.com - Investing.com South Africa
PTPI stock plunges to 52-week low of $0.05 amid market challenges - Investing.com India
Petros Pharmaceuticals modifies terms with investors - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Petros Pharmaceuticals, Inc. SEC 10-K Report - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Petros Pharmaceuticals enters collaboration with big data, analytics firm - MSN
Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
3 Penny Stocks to Watch Now, 3/27/25 - TipRanks
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket - Benzinga
"Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA, - openPR
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit? - Yahoo Finance
Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Apellis Pharmaceuticals, Inc. (APLS) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Petro-Victory Energy Corp Announces Extension to US $1,700,000 Note - Yahoo Finance
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst? - Yahoo Finance
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme - Yahoo Finance
Innovations In Medical Technology And Materials Drive Advancements In Erectile Dysfunction Treatments: Key ... - WhaTech
EXCLUSIVE: MIRA Pharmaceuticals Signs To Acquire SKNY Pharmaceuticals, Expand Pipeline Into Weight Loss And Smoking Cessation Drug - Yahoo Finance
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Petros Pharmaceuticals enhances Rx-to-OTC switch technology By Investing.com - Investing.com South Africa
Petros Pharmaceuticals enhances Rx-to-OTC switch technology - Investing.com
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications - ACCESS Newswire
Petros Pharmaceuticals Targets $38B Self-Care Market with Game-Changing AI Drug Platform - StockTitan
PTPI stock plunges to 52-week low of $0.07 amid market challenges By Investing.com - Investing.com South Africa
PTPI stock plunges to 52-week low of $0.07 amid market challenges - Investing.com Australia
Nvidia GTC 2025: What to expect from Nvidia's biggest event of the year - Yahoo Finance
PTPI’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now - Yahoo Finance
Petro-Victory Energy and BlueOak Investments to acquire Capixaba Energia - Yahoo Finance
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - Yahoo Finance
Entrada Therapeutics, Inc. Just Beat EPS By 55%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Internationally Published, Head-to-Head Data From India of Petros Pharmaceuticals' STENDRA(R) (Avanafil) Tablets Reported Improvement in Erectile Function Compared to Sildenafil and Baseline After 12 Weeks of Therapy - ACCESS Newswire
Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More - Yahoo Finance
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022 - ACCESS Newswire
New FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy - ACCESS Newswire
Petros Pharmaceuticals Inc Azioni (PTPI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):